GM-CSF as Adjuvant Therapy of Melanoma

NCT00350597 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Northern California Melanoma Center

Collaborators